Kevin Michels-Kim

Ever thought of clinical trials as a last resort? Think again. Tina Aswani flips that narrative in this episode, showing how trials can offer VIP-level care, early intervention, and a shot at revolutionizing treatment options. From debunking placebo myths to advocating for diversity, she’s here to challenge the status quo—and trust us, she’s not pulling any punches. If you’re in the life sciences and care about patients (like, really care), this one’s for you

Join us for a sharp and engaging chat with Patrick James Lynch, a powerhouse advocate and storyteller in the hemophilia community. In this episode, Patrick uncovers how social media and peer learning shape patient education, and why expanding MSLs' roles to include patient partnerships could redefine healthcare communication.

Join us for an insightful conversation with Ella Balasa, a patient expert and advocate with extensive experience in clinical trial co-design. This episode explores how early patient involvement can transform clinical research and development, building on Merakoi's commitment to patient-centered healthcare innovation.

How User Research Shapes Health Innovation Imagine you're a master chef. You've spent months crafting the perfect dish, a combination of exotic flavors that will revolutionize the culinary world. You're about to present it to a room full of eager foodies. But wait, you skipped the taste tests, and now, as the first bites are […]